Om mig
Dr Anders Gustavsson holds an MSc from the Stockholm School of Economics and a PhD in Health Economics from Karolinska Institutet, Sweden. During his PhD studies, Anders developed new methods for the economic evaluation of treatment for Alzheimer’s disease.
Anders has worked with health economics since 2005, with particular focus on neuroscience. Anders is cofounder and partner at Quantify, a consultancy within health economics, outcomes research and real world evidence. As a consultant, Anders has worked with pharma and biotech companies, patient organisations, health care providers and government institutions.
He has a broad competence within research and has co-authored about 50 peer-reviewed papers including registry studies, prospective cohorts, within-trial analysis, patient- and caregiver preference studies and decision analytic models. Anders was coordinator and first author of the European study on the costs of brain disorders (2010), initiated by European Brain Council.
He is affiliated to Karolinska Institutet and a steering group member of the International Pharmaco-Economic Collaboration on Alzheimer’s disease (IPECAD). He also sits on the board of Swedish cognitive testing company Mindmore.